Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study.

BMC Endocr Disord · 2020 · PMC7031983 · PMID 32075620

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

When examining the presence of ≥2 valves with grade 2+ valvular regurgitation, cabergoline only users had higher age-sex-adjusted odds compared with bromocriptine only users (adjusted odds ratio 8.4, 95% CI: 1.0–72.2, P = 0.05), as was combined exposure (adjusted odds ratio 8.8, 95% CI: 1.0–75.8, P = 0.05) that was of borderline significance.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.